India Pesticides Q1 FY27 Revenue at ₹256 Cr, EBITDA at ₹39 Cr; EU Fungicide Approval Received
India Pesticides reported Q1 FY27 revenue of ₹256 crore, down 9.2% YoY, and EBITDA of ₹39 crore, down 25.0% YoY. PAT stood at ₹23 crore. The company received Technical Equivalence (TEQ) approval from the EU for a fungicide product, bolstering its export potential. Management cited challenging domestic demand and cost pressures.
The decline in quarterly financial performance has a moderate negative impact, while the EU approval for a fungicide product offers a positive outlook for future export growth, balancing the overall impact.
While the company received a significant EU approval for a fungicide, the financial results for the quarter show a year-on-year decline in revenue and profit, indicating mixed performance.
India Pesticides Limited (IPL) has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported total revenue from operations of ₹256 crore, a year-on-year decrease of 9.2%. EBITDA for the quarter stood at ₹39 crore, down 25.0% YoY, with an EBITDA margin of 15.4%. Profit After Tax (PAT) was ₹23 crore, a decline of 34.3% YoY.
Despite a challenging domestic agrochemical market, which saw softer demand for key herbicides like Pretilachlor, export sales remained stable. Higher employee and fuel costs, along with elevated channel inventory, impacted profitability during the quarter. The company's Gross Profit remained stable at ₹127 crore with an improved margin of 49.6%.
A significant achievement during the quarter was the receipt of Technical Equivalence (TEQ) approval from the European Union for one of its fungicide products. This approval is expected to strengthen IPL's presence in international markets and create opportunities for export business expansion. The company continues to focus on operational efficiency, cost management, and disciplined execution.
Looking ahead, IPL remains confident in its growth prospects, driven by improving demand, favourable agricultural conditions, and a continued focus on operational efficiencies. The company plans to strengthen its product portfolio, expand its international presence, and enhance manufacturing capabilities. IPL's integrated value chain, strong customer relationships, and commitment to innovation position it for sustainable growth.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.